Revolution Medicines, Inc 10-Q for FY2026 Q2
Revolution Medicines, Inc. (RVMD)
10-Q
2026-08-05
For: 2026-06-30
View Original
Added on
August 05, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on August 5, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $644.37M
- compared with a net loss of $247.79M a year earlier
- Diluted EPS
- -$3.06
- compared with -$1.31 a year earlier